Suzhou Ribo Life Science Co (HKSE:06938) ROCE %: -123.95% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06938 Suzhou Ribo Life Science Co Ltd HKSE:06938
9 GF Score
Price HK$54.15
! 2 Warning Signs
View Full Analysis

What is Suzhou Ribo Life Science Co ROCE %?

Suzhou Ribo Life Science Co HKSE:06938 -4.07% 9 ROCE % is -123.95% as of Dec. 2025. GuruFocus rates HKSE:06938 with a GF Score™ of 9/100. The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Suzhou Ribo Life Science Co's annualized ROCE % for the quarter that ended in Dec. 2025 was -123.95%.

Suzhou Ribo Life Science Co  (HKSE:06938) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Suzhou Ribo Life Science Co ROCE % Related Terms

Suzhou Ribo Life Science Co ROCE % Historical Data

* Premium members only.

The historical data trend for Suzhou Ribo Life Science Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Suzhou Ribo Life Science Co ROCE % Chart

Suzhou Ribo Life Science Co Annual Data
Trend Dec23 Dec24 Dec25
ROCE %
-107.61 -74.60 -112.68

Suzhou Ribo Life Science Co Semi-Annual Data
Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
ROCE % Get a 7-Day Free Trial -56.37 -106.04 -58.12 -123.95 14.01
HKSE:06938
9GF Score
Suzhou Ribo Life Science Co Ltd HKSE:06938
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Suzhou Ribo Life Science Co ROCE % Calculation

Suzhou Ribo Life Science Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-290.672/( ( (694.903 - 442.343) + (927.758 - 664.391) )/ 2 )
=-290.672/( (252.56+263.367)/ 2 )
=-290.672/257.9635
=-112.68 %

Suzhou Ribo Life Science Co's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=-396.58/( ( (1093.694 - 717.178) + (927.758 - 664.391) )/ 2 )
=-396.58/( ( 376.516 + 263.367 )/ 2 )
=-396.58/319.9415
=-123.95 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -123.95% mean?
Suzhou Ribo Life Science Co (HKSE:06938) has a ROCE % of -123.95% as of Dec. 2025.
Is Suzhou Ribo Life Science Co's ROCE % too high?
Suzhou Ribo Life Science Co's current ROCE % is -123.95%. Overall, Suzhou Ribo Life Science Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Suzhou Ribo Life Science Co's ROCE % compare to VRTX and REGN?
Suzhou Ribo Life Science Co's ROCE % of -123.95% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Suzhou Ribo Life Science Co's current ROCE % is -123.95%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzhou Ribo Life Science Co stock overvalued right now?
Suzhou Ribo Life Science Co (HKSE:06938) has a current ROCE % of -123.95%. The current ROCE % is -123.95%. Suzhou Ribo Life Science Co's overall GF Score™ is 9/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Suzhou Ribo Life Science Co (HKSE:06938), the current ROCE % is -123.95% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Suzhou Ribo Life Science Co Business Description

Address No. 168 Yuanfeng Road, Yushan Town, Jiangsu Province, Kunshan, CHN, 215300
Suzhou Ribo Life Science Co Ltd is a biopharmaceutical company engaged in oligonucleotide R&D, with a focus on siRNA therapeutics. The company's pipeline focuses on cardiovascular, metabolic, renal and liver diseases. Its pipeline includes RBD4059, RBD5044, RBD7007, RBD1119, RBD3103, SR122, SR126, RBD1016, SR112/SR113, among others. It has one reportable operating segment.
9GF Score

Get the complete analysis for HKSE:06938

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$54.15
Price